 | • レポートコード：GIR-105X02011 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、アザシチジン注射のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。アザシチジン注射の種類別市場規模（50mg、100mg）、用途別市場規模（高リスク骨髄異形成症候群（MDS）、急性骨髄性白血病（AML）、慢性骨髄単球性白血病（CMML）、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・アザシチジン注射の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Celgene、Mylan、Shilpa Medicare、Accord Healthcare、Natco Pharma、Dr. Reddy's Laboratories、CTTQ、Huiyu Pharmaceutital、Eurohealth ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：50mg、100mg ・用途別分析2016年-2026年：高リスク骨髄異形成症候群（MDS）、急性骨髄性白血病（AML）、慢性骨髄単球性白血病（CMML）、その他 ・アザシチジン注射の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・アザシチジン注射のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・アザシチジン注射のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・アザシチジン注射の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・アザシチジン注射の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Azacitidine Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Azacitidine Injection size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Azacitidine Injection market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Azacitidine Injection market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
50mg
100mg
Market segment by Application can be divided into
Higher-risk myelodysplastic syndromes (MDS)
Acute Myeloid Leukemia (AML)
Chronic Myelomonocytic Leukemia (CMML)
Others
The key market players for global Azacitidine Injection market are listed below:
Celgene
Mylan
Shilpa Medicare
Accord Healthcare
Natco Pharma
Dr. Reddy’s Laboratories
CTTQ
Huiyu Pharmaceutital
Eurohealth
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Azacitidine Injection Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Azacitidine Injection Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 50mg
1.2.3 100mg
1.3 Market Analysis by Application
1.3.1 Overview: Global Azacitidine Injection Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Higher-risk myelodysplastic syndromes (MDS)
1.3.3 Acute Myeloid Leukemia (AML)
1.3.4 Chronic Myelomonocytic Leukemia (CMML)
1.3.5 Others
1.4 Global Azacitidine Injection Market Size & Forecast
1.4.1 Global Azacitidine Injection Sales in Value (2016-2026))
1.4.2 Global Azacitidine Injection Sales in Volume (2016-2026)
1.4.3 Global Azacitidine Injection Price by Type (2016-2026) & (US$/Unit)
1.5 Global Azacitidine Injection Production Capacity Analysis
1.5.1 Global Azacitidine Injection Total Production Capacity (2016-2026)
1.5.2 Global Azacitidine Injection Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Azacitidine Injection Market Drivers
1.6.2 Azacitidine Injection Market Restraints
1.6.3 Azacitidine Injection Trends Analysis
2 Manufacturers Profiles
2.1 Celgene
2.1.1 Celgene Details
2.1.2 Celgene Major Business
2.1.3 Celgene Azacitidine Injection Product and Services
2.1.4 Celgene Azacitidine Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Mylan
2.2.1 Mylan Details
2.2.2 Mylan Major Business
2.2.3 Mylan Azacitidine Injection Product and Services
2.2.4 Mylan Azacitidine Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Shilpa Medicare
2.3.1 Shilpa Medicare Details
2.3.2 Shilpa Medicare Major Business
2.3.3 Shilpa Medicare Azacitidine Injection Product and Services
2.3.4 Shilpa Medicare Azacitidine Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Accord Healthcare
2.4.1 Accord Healthcare Details
2.4.2 Accord Healthcare Major Business
2.4.3 Accord Healthcare Azacitidine Injection Product and Services
2.4.4 Accord Healthcare Azacitidine Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Natco Pharma
2.5.1 Natco Pharma Details
2.5.2 Natco Pharma Major Business
2.5.3 Natco Pharma Azacitidine Injection Product and Services
2.5.4 Natco Pharma Azacitidine Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Dr. Reddy’s Laboratories
2.6.1 Dr. Reddy’s Laboratories Details
2.6.2 Dr. Reddy’s Laboratories Major Business
2.6.3 Dr. Reddy’s Laboratories Azacitidine Injection Product and Services
2.6.4 Dr. Reddy’s Laboratories Azacitidine Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 CTTQ
2.7.1 CTTQ Details
2.7.2 CTTQ Major Business
2.7.3 CTTQ Azacitidine Injection Product and Services
2.7.4 CTTQ Azacitidine Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Huiyu Pharmaceutital
2.8.1 Huiyu Pharmaceutital Details
2.8.2 Huiyu Pharmaceutital Major Business
2.8.3 Huiyu Pharmaceutital Azacitidine Injection Product and Services
2.8.4 Huiyu Pharmaceutital Azacitidine Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Eurohealth
2.9.1 Eurohealth Details
2.9.2 Eurohealth Major Business
2.9.3 Eurohealth Azacitidine Injection Product and Services
2.9.4 Eurohealth Azacitidine Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Azacitidine Injection Sales by Manufacturer
3.1 Global Azacitidine Injection Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Azacitidine Injection Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Azacitidine Injection
3.4 Market Concentration Rate
3.4.1 Top 3 Azacitidine Injection Manufacturer Market Share
3.4.2 Top 6 Azacitidine Injection Manufacturer Market Share
3.5 Global Azacitidine Injection Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Azacitidine Injection Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Azacitidine Injection Market Size by Region
4.1.1 Global Azacitidine Injection Sales in Volume by Region (2016-2026)
4.1.2 Global Azacitidine Injection Revenue by Region (2016-2026)
4.2 North America Azacitidine Injection Revenue (2016-2026)
4.3 Europe Azacitidine Injection Revenue (2016-2026)
4.4 Asia-Pacific Azacitidine Injection Revenue (2016-2026)
4.5 South America Azacitidine Injection Revenue (2016-2026)
4.6 Middle East and Africa Azacitidine Injection Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Azacitidine Injection Sales in Volume by Type (2016-2026)
5.2 Global Azacitidine Injection Revenue by Type (2016-2026)
5.3 Global Azacitidine Injection Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Azacitidine Injection Sales in Volume by Application (2016-2026)
6.2 Global Azacitidine Injection Revenue by Application (2016-2026)
6.3 Global Azacitidine Injection Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Azacitidine Injection Sales by Type (2016-2026)
7.2 North America Azacitidine Injection Sales by Application (2016-2026)
7.3 North America Azacitidine Injection Market Size by Country
7.3.1 North America Azacitidine Injection Sales in Volume by Country (2016-2026)
7.3.2 North America Azacitidine Injection Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Azacitidine Injection Sales by Type (2016-2026)
8.2 Europe Azacitidine Injection Sales by Application (2016-2026)
8.3 Europe Azacitidine Injection Market Size by Country
8.3.1 Europe Azacitidine Injection Sales in Volume by Country (2016-2026)
8.3.2 Europe Azacitidine Injection Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Azacitidine Injection Sales by Type (2016-2026)
9.2 Asia-Pacific Azacitidine Injection Sales by Application (2016-2026)
9.3 Asia-Pacific Azacitidine Injection Market Size by Region
9.3.1 Asia-Pacific Azacitidine Injection Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Azacitidine Injection Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Azacitidine Injection Sales by Type (2016-2026)
10.2 South America Azacitidine Injection Sales by Application (2016-2026)
10.3 South America Azacitidine Injection Market Size by Country
10.3.1 South America Azacitidine Injection Sales in Volume by Country (2016-2026)
10.3.2 South America Azacitidine Injection Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Azacitidine Injection Sales by Type (2016-2026)
11.2 Middle East & Africa Azacitidine Injection Sales by Application (2016-2026)
11.3 Middle East & Africa Azacitidine Injection Market Size by Country
11.3.1 Middle East & Africa Azacitidine Injection Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Azacitidine Injection Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Azacitidine Injection Typical Distributors
12.3 Azacitidine Injection Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Azacitidine Injection Revenue by Type, (USD Million), 2021-2026
Table 2. Global Azacitidine Injection Revenue by Application, (USD Million), 2021-2026
Table 3. Celgene Basic Information, Manufacturing Base and Competitors
Table 4. Celgene Major Business
Table 5. Celgene Azacitidine Injection Product and Services
Table 6. Celgene Azacitidine Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Mylan Basic Information, Manufacturing Base and Competitors
Table 8. Mylan Major Business
Table 9. Mylan Azacitidine Injection Product and Services
Table 10. Mylan Azacitidine Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Shilpa Medicare Basic Information, Manufacturing Base and Competitors
Table 12. Shilpa Medicare Major Business
Table 13. Shilpa Medicare Azacitidine Injection Product and Services
Table 14. Shilpa Medicare Azacitidine Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Accord Healthcare Basic Information, Manufacturing Base and Competitors
Table 16. Accord Healthcare Major Business
Table 17. Accord Healthcare Azacitidine Injection Product and Services
Table 18. Accord Healthcare Azacitidine Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Natco Pharma Basic Information, Manufacturing Base and Competitors
Table 20. Natco Pharma Major Business
Table 21. Natco Pharma Azacitidine Injection Product and Services
Table 22. Natco Pharma Azacitidine Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Dr. Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
Table 24. Dr. Reddy's Laboratories Major Business
Table 25. Dr. Reddy's Laboratories Azacitidine Injection Product and Services
Table 26. Dr. Reddy's Laboratories Azacitidine Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. CTTQ Basic Information, Manufacturing Base and Competitors
Table 28. CTTQ Major Business
Table 29. CTTQ Azacitidine Injection Product and Services
Table 30. CTTQ Azacitidine Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Huiyu Pharmaceutital Basic Information, Manufacturing Base and Competitors
Table 32. Huiyu Pharmaceutital Major Business
Table 33. Huiyu Pharmaceutital Azacitidine Injection Product and Services
Table 34. Huiyu Pharmaceutital Azacitidine Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Eurohealth Basic Information, Manufacturing Base and Competitors
Table 36. Eurohealth Major Business
Table 37. Eurohealth Azacitidine Injection Product and Services
Table 38. Eurohealth Azacitidine Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Global Azacitidine Injection Sales by Manufacturer (2019-2021e) & (K Units)
Table 40. Global Azacitidine Injection Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 41. Market Position of Manufacturers in Azacitidine Injection, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 42. Global Azacitidine Injection Production Capacity by Company, (K Units): 2020 VS 2021
Table 43. Head Office and Azacitidine Injection Production Site of Key Manufacturer
Table 44. Global Azacitidine Injection Sales by Region (2016-2021e) & (K Units)
Table 45. Global Azacitidine Injection Sales by Region (2021-2026) & (K Units)
Table 46. Global Azacitidine Injection Revenue by Region (2016-2021e) & (USD Million)
Table 47. Global Azacitidine Injection Revenue by Region (2021-2026) & (USD Million)
Table 48. Global Azacitidine Injection Sales by Type (2016-2021e) & (K Units)
Table 49. Global Azacitidine Injection Sales by Type (2021-2026) & (K Units)
Table 50. Global Azacitidine Injection Revenue by Type (2016-2021e) & (USD Million)
Table 51. Global Azacitidine Injection Revenue by Type (2021-2026) & (USD Million)
Table 52. Global Azacitidine Injection Price by Type (2016-2021e) & (US$/Unit)
Table 53. Global Azacitidine Injection Price by Type (2021-2026) & (US$/Unit)
Table 54. Global Azacitidine Injection Sales by Application (2016-2021e) & (K Units)
Table 55. Global Azacitidine Injection Sales by Application (2021-2026) & (K Units)
Table 56. Global Azacitidine Injection Revenue by Application (2016-2021e) & (USD Million)
Table 57. Global Azacitidine Injection Revenue by Application (2021-2026) & (USD Million)
Table 58. Global Azacitidine Injection Price by Application (2016-2021e) & (US$/Unit)
Table 59. Global Azacitidine Injection Price by Application (2021-2026) & (US$/Unit)
Table 60. North America Azacitidine Injection Sales by Country (2016-2021e) & (K Units)
Table 61. North America Azacitidine Injection Sales by Country (2021-2026) & (K Units)
Table 62. North America Azacitidine Injection Revenue by Country (2016-2021e) & (USD Million)
Table 63. North America Azacitidine Injection Revenue by Country (2021-2026) & (USD Million)
Table 64. North America Azacitidine Injection Sales by Type (2016-2021e) & (K Units)
Table 65. North America Azacitidine Injection Sales by Type (2021-2026) & (K Units)
Table 66. North America Azacitidine Injection Sales by Application (2016-2021e) & (K Units)
Table 67. North America Azacitidine Injection Sales by Application (2021-2026) & (K Units)
Table 68. Europe Azacitidine Injection Sales by Country (2016-2021e) & (K Units)
Table 69. Europe Azacitidine Injection Sales by Country (2021-2026) & (K Units)
Table 70. Europe Azacitidine Injection Revenue by Country (2016-2021e) & (USD Million)
Table 71. Europe Azacitidine Injection Revenue by Country (2021-2026) & (USD Million)
Table 72. Europe Azacitidine Injection Sales by Type (2016-2021e) & (K Units)
Table 73. Europe Azacitidine Injection Sales by Type (2021-2026) & (K Units)
Table 74. Europe Azacitidine Injection Sales by Application (2016-2021e) & (K Units)
Table 75. Europe Azacitidine Injection Sales by Application (2021-2026) & (K Units)
Table 76. Asia-Pacific Azacitidine Injection Sales by Region (2016-2021e) & (K Units)
Table 77. Asia-Pacific Azacitidine Injection Sales by Region (2021-2026) & (K Units)
Table 78. Asia-Pacific Azacitidine Injection Revenue by Region (2016-2021e) & (USD Million)
Table 79. Asia-Pacific Azacitidine Injection Revenue by Region (2021-2026) & (USD Million)
Table 80. Asia-Pacific Azacitidine Injection Sales by Type (2016-2021e) & (K Units)
Table 81. Asia-Pacific Azacitidine Injection Sales by Type (2021-2026) & (K Units)
Table 82. Asia-Pacific Azacitidine Injection Sales by Application (2016-2021e) & (K Units)
Table 83. Asia-Pacific Azacitidine Injection Sales by Application (2021-2026) & (K Units)
Table 84. South America Azacitidine Injection Sales by Country (2016-2021e) & (K Units)
Table 85. South America Azacitidine Injection Sales by Country (2021-2026) & (K Units)
Table 86. South America Azacitidine Injection Revenue by Country (2016-2021e) & (USD Million)
Table 87. South America Azacitidine Injection Revenue by Country (2021-2026) & (USD Million)
Table 88. South America Azacitidine Injection Sales by Type (2016-2021e) & (K Units)
Table 89. South America Azacitidine Injection Sales by Type (2021-2026) & (K Units)
Table 90. South America Azacitidine Injection Sales by Application (2016-2021e) & (K Units)
Table 91. South America Azacitidine Injection Sales by Application (2021-2026) & (K Units)
Table 92. Middle East & Africa Azacitidine Injection Sales by Country (2016-2021e) & (K Units)
Table 93. Middle East & Africa Azacitidine Injection Sales by Country (2021-2026) & (K Units)
Table 94. Middle East & Africa Azacitidine Injection Revenue by Country (2016-2021e) & (USD Million)
Table 95. Middle East & Africa Azacitidine Injection Revenue by Country (2021-2026) & (USD Million)
Table 96. Middle East & Africa Azacitidine Injection Sales by Type (2016-2021e) & (K Units)
Table 97. Middle East & Africa Azacitidine Injection Sales by Type (2021-2026) & (K Units)
Table 98. Middle East & Africa Azacitidine Injection Sales by Application (2016-2021e) & (K Units)
Table 99. Middle East & Africa Azacitidine Injection Sales by Application (2021-2026) & (K Units)
Table 100. Direct Channel Pros & Cons
Table 101. Indirect Channel Pros & Cons
Table 102. Azacitidine Injection Typical Distributors
Table 103. Azacitidine Injection Typical Customers
List of Figures
Figure 1. Azacitidine Injection Picture
Figure 2. Global Azacitidine Injection Sales Market Share by Type in 2020
Figure 3. 50mg
Figure 4. 100mg
Figure 5. Global Azacitidine Injection Sales Market Share by Application in 2020
Figure 6. Higher-risk myelodysplastic syndromes (MDS)
Figure 7. Acute Myeloid Leukemia (AML)
Figure 8. Chronic Myelomonocytic Leukemia (CMML)
Figure 9. Others
Figure 10. Global Azacitidine Injection Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 11. Global Azacitidine Injection Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. United States Azacitidine Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Canada Azacitidine Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Mexico Azacitidine Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Germany Azacitidine Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. France Azacitidine Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. United Kingdom Azacitidine Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Russia Azacitidine Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Italy Azacitidine Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. China Azacitidine Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Japan Azacitidine Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Korea Azacitidine Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. India Azacitidine Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Southeast Asia Azacitidine Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Australia Azacitidine Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Brazil Azacitidine Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Egypt Azacitidine Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Saudi Arabia Azacitidine Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. South Africa Azacitidine Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Turkey Azacitidine Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Global Azacitidine Injection Sales (2016-2026) & (K Units)
Figure 32. Global Azacitidine Injection Production Capacity (2016-2026) & (K Units)
Figure 33. Global Azacitidine Injection Production Capacity by Geographic Region: 2020 VS 2021
Figure 34. Azacitidine Injection Market Drivers
Figure 35. Azacitidine Injection Market Restraints
Figure 36. Azacitidine Injection Market Trends
Figure 37. Global Azacitidine Injection Sales Market Share by Manufacturer in 2020
Figure 38. Global Azacitidine Injection Revenue Market Share by Manufacturer in 2020
Figure 39. Azacitidine Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 40. Top 3 Azacitidine Injection Manufacturer (Revenue) Market Share in 2020
Figure 41. Top 6 Azacitidine Injection Manufacturer (Revenue) Market Share in 2020
Figure 42. Global Azacitidine Injection Sales Market Share by Region (2016-2026)
Figure 43. Global Azacitidine Injection Revenue Market Share by Region (2016-2026)
Figure 44. North America Azacitidine Injection Revenue (2016-2026) & (USD Million)
Figure 45. Europe Azacitidine Injection Revenue (2016-2026) & (USD Million)
Figure 46. Asia-Pacific Azacitidine Injection Revenue (2016-2026) & (USD Million)
Figure 47. South America Azacitidine Injection Revenue (2016-2026) & (USD Million)
Figure 48. Middle East & Africa Azacitidine Injection Revenue (2016-2026) & (USD Million)
Figure 49. Global Azacitidine Injection Sales Market Share by Type (2016-2026)
Figure 50. Global Azacitidine Injection Revenue Market Share by Type (2016-2026)
Figure 51. Global Azacitidine Injection Price by Type (2016-2026) & (US$/Unit)
Figure 52. Global Azacitidine Injection Sales Market Share by Application (2016-2026)
Figure 53. Global Azacitidine Injection Revenue Market Share by Application (2016-2026)
Figure 54. Global Azacitidine Injection Price by Application (2016-2026) & (US$/Unit)
Figure 55. North America Azacitidine Injection Sales Market Share by Country (2016-2026)
Figure 56. North America Azacitidine Injection Revenue Market Share by Country (2016-2026)
Figure 57. North America Azacitidine Injection Sales Market Share by Type (2016-2026)
Figure 58. North America Azacitidine Injection Sales Market Share by Application (2016-2026)
Figure 59. Europe Azacitidine Injection Sales Market Share by Country (2016-2026)
Figure 60. Europe Azacitidine Injection Revenue Market Share by Country (2016-2026)
Figure 61. Europe Azacitidine Injection Sales Market Share by Type (2016-2026)
Figure 62. Europe Azacitidine Injection Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific Azacitidine Injection Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Azacitidine Injection Revenue Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Azacitidine Injection Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Azacitidine Injection Sales Market Share by Application (2016-2026)
Figure 67. South America Azacitidine Injection Sales Market Share by Country (2016-2026)
Figure 68. South America Azacitidine Injection Revenue Market Share by Country (2016-2026)
Figure 69. South America Azacitidine Injection Sales Market Share by Type (2016-2026)
Figure 70. South America Azacitidine Injection Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa Azacitidine Injection Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Azacitidine Injection Revenue Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Azacitidine Injection Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Azacitidine Injection Sales Market Share by Application (2016-2026)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source
急性骨髄性白血病治療の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Acute myeloid leukemia is the second frequent type (after acute lymphocytic leukemia) of leukemia diagnosed in infants. About 15% of children from birth to 19 years of age diagnosed with leukemia have acute myeloid leukemia. The risk of acute myeloid leukemia is closely associated with age. About 90…- 急性骨髄性白血病薬の世界市場2018-2025 Acute myeloid leukemia is the second frequent type (after acute lymphocytic leukemia) of leukemia diagnosed in infants. About 15% of children from birth to 19 years of age diagnosed with leukemia have acute myeloid leukemia. The risk of acute myeloid leukemia is closely associated with age. About 90…
- 慢性リンパ球性白血病の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Chronic lymphocytic leukemia is a type of cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell). Chronic lymphocytic leukemia (also called CLL) is a blood and bone marrow disease that usually gets worse slowly. Scope of the Report: This report focuses on the Chronic…
- 急性リンパ芽球性白血病の世界市場2018-2025 Acute lymphoblastic leukemia (ALL) is a cancer of the lymphoid line of blood cells characterized by the development of large numbers of immature lymphocytes.In 2018, the global Acute Lymphoblastic Leukemia market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of …
- 急性リンパ芽球性白血病治療の世界市場2018-2025 Acute lymphoblastic leukemia (ALL) is a cancer of the lymphoid line of blood cells characterized by the development of large numbers of immature lymphocytes.In 2018, the global Acute Lymphoblastic Leukemia Therapeutics market size was xx million US$ and is forecast to xx million US in 2025, growing …